An Act relative to promoting comprehensive transparency in the pharmaceutical industry
By Representative Coppinger of Boston, a petition (accompanied by bill, House, No. 1176) of Edward F. Coppinger and others relative to promoting comprehensive transparency in the pharmaceutical industry. Health Care Financing.
Bill History
| Date | Branch | Action |
|---|---|---|
| 2/16/2023 | House | Referred to the committee on Health Care Financing |
| 2/16/2023 | Senate | Senate concurred |
| 5/23/2023 | Joint |
|
| 6/2/2023 | Joint |
|
| 6/5/2023 | Joint | Hearing rescheduled to 06/06/2023 from 10:00 AM-04:00 PM in A-2 |
| 10/30/2023 | Senate | Accompanied a new draft, see S2492 |
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.